GlassScriptPhysician profile
Lindsey Gardner
NPI 1366615098
$1,038.57
in general payments reported to CMS, 2019-2025
15 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $168 · 2022: $130 · 2023: $274 · 2024: $359 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $740.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $219.51 | 2022-2025 | |
| Janssen Scientific Affairs, LLC | $200.63 | 2021-2024 | |
| Intercept Pharmaceuticals, INC. | $156.00 | 2021-2023 | Ocaliva |
| Takeda Pharmaceuticals U.S.A., INC. | $118.47 | 2023-2025 | Entyvio |
| Janssen Biotech, INC. | $98.16 | 2022-2025 | Tremfya, Stelara |
| Lilly USA, LLC | $50.30 | 2024 | Omvoh |
| Celgene Corporation | $42.93 | 2022-2023 | Zeposia |
| Pfizer INC. | $29.76 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $29.20 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $18.33 | 2024 | Bylvay |
| Orphalan INC | $16.07 | 2025 | Cuvrior |
| Enterra Medical, INC. | $15.38 | 2022 | |
| Braintree Laboratories, INC. | $15.33 | 2024 | Suflave |
| Aimmune Therapeutics, INC. | $14.96 | 2025 | Vowst |
| Collegium Pharmaceutical, INC. | $13.54 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Gardner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.